Crossmark Global Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.6M Buy
228,026
+11,574
+5% +$536K 0.17% 145
2025
Q1
$13.2M Buy
216,452
+25,638
+13% +$1.56M 0.23% 106
2024
Q4
$10.8M Buy
190,814
+5,488
+3% +$310K 0.2% 129
2024
Q3
$9.59M Sell
185,326
-160,079
-46% -$8.28M 0.17% 148
2024
Q2
$14.3M Buy
345,405
+27,509
+9% +$1.14M 0.27% 81
2024
Q1
$17.2M Buy
317,896
+26,696
+9% +$1.45M 0.33% 65
2023
Q4
$14.9M Buy
291,200
+50,406
+21% +$2.59M 0.31% 72
2023
Q3
$13.6M Sell
240,794
-8,343
-3% -$470K 0.31% 78
2023
Q2
$15.3M Buy
249,137
+22,291
+10% +$1.37M 0.33% 67
2023
Q1
$15.7M Buy
226,846
+12,225
+6% +$847K 0.37% 61
2022
Q4
$15.4M Buy
214,621
+116,603
+119% +$8.39M 0.38% 61
2022
Q3
$6.97M Buy
98,018
+45,153
+85% +$3.21M 0.19% 135
2022
Q2
$4.07M Buy
52,865
+5,915
+13% +$455K 0.11% 221
2022
Q1
$3.43M Sell
46,950
-2,668
-5% -$195K 0.08% 274
2021
Q4
$3.09M Buy
49,618
+290
+0.6% +$18.1K 0.07% 288
2021
Q3
$2.92M Sell
49,328
-851
-2% -$50.4K 0.07% 291
2021
Q2
$3.35M Sell
50,179
-6,056
-11% -$405K 0.08% 261
2021
Q1
$3.55M Buy
56,235
+1,218
+2% +$76.9K 0.09% 238
2020
Q4
$3.41M Sell
55,017
-48
-0.1% -$2.98K 0.09% 257
2020
Q3
$3.32M Sell
55,065
-1,862
-3% -$112K 0.09% 234
2020
Q2
$3.35M Buy
56,927
+4,842
+9% +$285K 0.1% 234
2020
Q1
$2.9M Buy
52,085
+1,907
+4% +$106K 0.1% 222
2019
Q4
$3.22M Buy
50,178
+18,862
+60% +$1.21M 0.09% 255
2019
Q3
$1.59M Sell
31,316
-6,740
-18% -$342K 0.05% 426
2019
Q2
$1.73M Sell
38,056
-206
-0.5% -$9.34K 0.05% 428
2019
Q1
$1.83M Sell
38,262
-1,555
-4% -$74.2K 0.05% 401
2018
Q4
$2.07M Buy
39,817
+1,260
+3% +$65.5K 0.06% 349
2018
Q3
$2.39M Buy
38,557
+3,470
+10% +$215K 0.06% 357
2018
Q2
$1.94M Sell
35,087
-6,170
-15% -$341K 0.05% 397
2018
Q1
$2.61M Sell
41,257
-2,432
-6% -$154K 0.07% 345
2017
Q4
$2.68M Buy
43,689
+692
+2% +$42.4K 0.06% 350
2017
Q3
$2.74M Buy
+42,997
New +$2.74M 0.07% 329
2016
Q3
$2.74M Buy
+42,997
New +$2.74M 0.07% 329